Mastocytosis, Systemic - 25 Studies Found
Active, not recruiting |
: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia : Leukemia : 2008-10-28 : Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati |
Completed |
: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis :
: Drug: tanespimycin |
Completed |
: Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis :
: 2008-10-08 : Drug: thalidomide |
Recruiting |
: A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies :
|
Recruiting |
: A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap :
|